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Abstract
Background and Aims: The intestinal microbiota is closely associated with resident memory 
lymphocytes in mucosal tissue. We sought to understand how acquired cellular and humoral 
immunity to the microbiota differ in health versus inflammatory bowel disease [IBD].
Methods: Resident memory T cells [Trm] in colonic biopsies and local antibody responses to 
intraepithelial microbes were analysed. Systemic antigen-specific immune T and B cell memory to 
a panel of commensal microbes was assessed.
Results: Systemically, healthy blood showed CD4 and occasional CD8 memory T cell responses to 
selected intestinal bacteria, but few memory B cell responses. In IBD, CD8 memory T cell responses 
decreased although B cell responses and circulating plasmablasts increased. Possibly secondary 
to loss of systemic CD8 T cell responses in IBD, dramatically reduced numbers of mucosal CD8+ Trm 
and γδ T cells were observed. IgA responses to intraepithelial bacteria were increased. Colonic Trm 
expressed CD39 and CD73 ectonucleotidases, characteristic of regulatory T cells. Cytokines/factors 
required for Trm differentiation were identified, and in vitro-generated Trm expressed regulatory 
T cell function via CD39. Cognate interaction between T cells and dendritic cells induced T-bet 
expression in dendritic cells, a key mechanism in regulating cell-mediated mucosal responses.
Conclusions: A previously unrecognised imbalance exists between cellular and humoral immunity 
to the microbiota in IBD, with loss of mucosal T cell-mediated barrier immunity and uncontrolled 
antibody responses. Regulatory function of Trm may explain their association with intestinal 
health. Promoting Trm and their interaction with dendritic cells, rather than immunosuppression, 
may reinforce tissue immunity, improve barrier function, and prevent B cell dysfunction in 
microbiota-associated disease and IBD aetiology.
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1. Introduction
Large numbers of lymphocytes reside in the intestinal mucosa 
and play a key role in barrier function and immune surveillance. 
Immunity against infection is provided by long-lived memory T cells 
reactive to foreign antigens as well as antibody.1 Memory T cells can 
be broadly categorised into circulating [central memory and effector 
memory] and tissue-resident, non-recirculating cells called resident 
memory T cells [Trm].2 Trm provide potent barrier immunity in 
mucosal tissues due to their high motility, rapid reactivation of ef-
fector function, and ability to recruit further immune responses via 
cytokine [e.g. IFN-γ] secretion. However, the role of Trm in human 
disease is unclear, and how they interact with resident microbes that 
make up the intestinal microbiota is not understood.
Inflammatory bowel disease [IBD] is thought to be perpetu-
ated by intestinal microbial dysbiosis leading to episodic colitis 
[ulcerative colitis, UC] or localised inflammation anywhere along 
the gastrointestinal [GI] tract [Crohn’s disease, CD], mediated by 
Th17 or other subsets of CD4 T cells.3,4 Disease aetiology involves 
interaction of multiple genetic susceptibilities with environmental 
factors, including diet and lifestyle factors, that can affect the micro-
biota. However, most studies to date have focused on sequence-
based profiling of microbiomes in disease; how different microbial 
species interact with the immune system is not well understood. 
Mouse studies indicate the colonic microbiota is essential for re-
cruiting sufficient CD4 Foxp3-expressing regulatory T cells [Treg] 
to the colon to prevent inflammation.5,6 This suggests that IBD re-
sults from a failure of Treg-mediated tolerance to commensals in 
the GI tract.
Here we studied memory T cell responses to a panel of intes-
tinal commensal bacteria in IBD patients and healthy controls, and 
analysed Trm populations in the epithelium and lamina propria co-
lonic tissue where they are in close proximity to mucosa-associated 
microbes. Our data show that underlying disease in human IBD is 
associated with reduced CD8 T cell responses to commensal bacteria 
leading to Trm deficiency in the colon, and chronic B cell activation 
and excess IgA secretion associated with a loss of barrier immunity. 
We also show that human Trm express Treg function, and propose 
specific mechanisms to explain how loss of Trm:dendritic cell inter-
action could contribute to the development of inflammatory disease.
2. Methods
2.1. Study design
The study aimed to determine the role of resident memory T cells in 
IBD. Donors [age 16–80] were recruited to the study from outpatient 
clinics of St Mark’s Hospital and included those with a diagnosis of CD 
or UC, and healthy donors undergoing investigative endoscopy. None of 
the CD patients had a history of obstruction, perianal disease, or ileitis 
alone. Patients were recruited over a fixed period determined by ethical 
permission; no data were excluded at the end of the study. Additional 
healthy blood donors were recruited from hospital staff and visitors. 
Ethics approval was obtained from the Health Research Authority UK 
and London Brent Research Ethics Committee. Written informed con-
sent was received from participants before inclusion in the study.
2.2. Colonic intraepithelial lymphocytes 
[IEL], lamina propria lymphocytes [LPL], and 
intraepithelial microbe [IEM] isolation
Five left colon and five right colon biopsies [10 mg tissue each] were 
obtained from macroscopically non-lesional tissue sites at routine 
colonoscopy in all patients as described.7 IEL and IEM were released 
from biopsies using DTT/EDTA and harvested by centrifugation at 
300 g [5 min]. IEM were obtained by centrifugation of resulting super-
natants at 4500 g [20 min]. LPL were obtained by collagenase diges-
tion of remaining tissue; all cells were phenotyped and counted by flow 
cytometry. Cells were washed in PBS and stained for viability using 
LIVE/DEAD Fixable-near-IR stain [ThermoFisher] before addition of 
surface-staining antibodies in fetal calf serum. In some cases cells were 
then fixed/permeabilised for intranuclear staining using the Foxp3 
buffer set [ThermoFisher, as instructions]. Antibodies used are listed 
in Supplementary File 1, available as Supplementary data at ECCO-
JCC online. All samples were analysed on a BD Biosciences FACS 
Canto II and data were analysed by FlowJo software [Tree Star], with 
volumetric sampling determined using Perfect Count microspheresTM 
[Cytognos].
2.3. In vitro differentiation of Trm-like cells from 
human peripheral blood mononuclear cells 
Naïve CD8 T cells were purified by magnetic selection from healthy 
donor peripheral blood mononuclear cells [PBMC] using the naïve 
CD8 T cell isolation kit [Miltenyi Biotec] and were >98% CD8+ and 
>98% CD45RA+. Naïve CD8 T cells were stimulated with plate-bound 
anti-CD3 [1 µg/ml], soluble anti-CD28 [1 µg/ml], and IL-2 [5 ng/ml, 
Peprotech]. Further additions of TGF-β [3 ng/ml, R&D Systems], IFN-
β [10 ng/ml, R&D], all-trans retinoic acid [ATRA; 10 nM, Sigma], 
FICZ [AhR agonist; 100 nM, Tocris Bioscience] were made at the start 
of the 7-day culture. Cultured cells were washed in PBS, stained for 
viability and surface or intracellular markers as above. Tc1/Trm-like 
cells were analysed for cytokine production by re-stimulation with 
PMA [20 ng/ml] + ionomycin [400 ng/ml] + monensin [3 µM] for 4 h 
before staining using Foxp3 staining buffer set.
2.4. Commensal-specific T and B cell memory 
proliferative responses
Commensal species were isolated from the caecum of healthy donors 
with the exception of Collinsella aerofaciens, which was from 
faeces.8–10 Strains were grown anaerobically in Hungate tubes con-
taining Wilkins-Chalgren broth [37°C for 24 h]. Aliquots [1 ml] were 
centrifuged [13 000 rpm for 10 min], supernatants removed, and cell 
pellets snap-frozen with dry ice before storage at -80°C. PBMC were 
obtained over Ficoll gradients and labelled with CellTrace VioletTM 
[1 µM, Life Technologies] according to manufacturer’s instructions, 
then cultured at 4 × 106/ml in XVIVO15 serum-free medium (Lonza, 
+ 50  µg/ml gentamycin [Sigma] and penicillin/streptomycin [Life 
Technologies, 1/100]); 2 × 105 killed bacteria from 19 species [as in 
Figure 5 below] were added to 0.2-ml cultures, and microbe-specific 
CD4+/CD8+ T cell and B cell responses were determined after 7 days’ 
culture. Cultured cells were analysed by staining with LIVE/DEAD 
stain, CD4/CD8/CD19/integrin-β7/CLA/CD39.
2.5. Suppression assays
A fraction of healthy donor PBMC were cryopreserved before isola-
tion of naïve CD8 T cells and differentiation into Tc1- or Trm-like 
cells, as described above. Cells were cultured at 0.5 × 106/ml in 0.4-
ml cultures; Tc1 cells were generated with anti-CD3/28+IL-2 only 
and Trm-like cells with addition of TGF-β, IFN-β, ATRA, and FICZ. 
After 7 days cells were washed and autologous PBMC thawed, be-
fore labelling with CellTrace VioletTM. Labelled target cells were 
cultured in U-bottom wells [0.2-ml XVIVO-15] at 106/ml with or 
without addition of unlabelled Tc1/Trm cells and CD39 inhibitor 
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ARL67156 [200 µM, Tocris Bioscience]. Cells were stimulated by 
addition of SEB [0.1 µg/ml, Sigma] and stained after 4  days with 
LIVE/DEAD stain, CD3/CD4/CD8/CD25. Cells were gated for 
CellTrace Violet+ CD8+ T cells, and fractions of cells which had div-
ided and upregulated CD25 assessed.
2.6. Induction of transcription factors and cytokines 
in DC
PBMC from healthy donors were cultured at 106/ml in RPMI-1640 
medium [Sigma] supplemented with 10% newborn calf serum 
[Sigma] and antibiotics as above. LPS [1 µg/ml], SEB [10 ng/ml, both 
Sigma], and anti-IFN-γ [50  µg/ml] or isotype control IgG1 were 
added. After overnight culture all cells were stimulated with LPS + 
poly I:C [1 µg/ml, Sigma] + monensin [3 µM] for a further 4 h and 
stained for lineage markers, HLA-DR/CD123/CD11c/T bet/TNF-α 
/IFN-α and LIVE/DEAD stain using Foxp3 buffer set. Gating for 
singlet mDC and pDC was performed as shown in Supplementary 
File 1. Strict gating for CD11c-negative cells was used to exclude 
mDC precursors from the pDC gate—this was confirmed by lack of 
staining for CD33, CX3CR1, and Axl.
2.7. Measurement of antibody responses
IEM were labelled with SYBR Green DNA stain [Life Technologies, 
1/100 000], anti-IgA-APC/anti-IgG-APC/Cy7, and analysed by flow 
cytometry to determine proportion [%] of bacteria coated with anti-
bodies in the gut. Circulating antibodies to commensal species were 
determined by incubation of plasma [1/10 in 0.1% BSA, 0.5 ml] with 
1 × 105 bacteria [30 min], followed by centrifugation [12 000 g, 10 
min] and staining as for IEM [or isotype controls for each sample]. 
Intact microbes were gated according to SYBR Green, and ratio of 
geometric mean fluorescence intensity of staining for test sample vs 
isotype control was used as measure of antibody titre. Plasma IgG 
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Figure 1. Human colonic Trm are identified by CD103 and express Runx3, T-bet, and regulatory T cell markers but not Foxp3. A: CD8 T cell and γδ T cell populations 
were identified in IEL fractions and stained for CD69/CD103 surface Trm markers; gated CD103+ cells were stained for intranuclear Runx3 and T-bet. B: CD4 and 
CD8 T cell populations were identified in LPL fractions and stained for CD69/CD103; gated CD103+ cells were stained for Runx3 and T-bet. C: IEL CD8+ and γδ T 
cell populations were stained for CD39/CD73 Treg-associated ectonucleotidases and CD8αβ to distinguish conventional vs innate-type lymphocytes. CD8αβ and 
CD8αα subsets were separately gated and T-bet and Runx3 expression shown, including isotype control staining for transcription factors. D: LPL CD4+ and CD8+ 
Trm-like populations were stained for surface CD39/CD73 and intranuclear Foxp3. Right panels show isotype control for Foxp3 stain. Staining is from right colon 
biopsies of healthy donors and is representative of at least five individual donors. Similar data were obtained in left colon. IEL, intraepithelial lymphocytes; LPL, 
lamina propria lymphocytes.
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antibodies to viruses were measured using ELISA kits from Abcam 
according to instructions.
2.8. Statistical analysis
GraphPad Prism 7 software [GraphPad, San Diego, CA] was used to 
plot and analyse the data. Clinical data were analysed by one-way 
ANOVA or, where populations were skewed, Kruskal-Wallis tests. 
For in vitro experiments, data were analysed using two-tailed paired 
t tests or one-way ANOVA for multiple experimental conditions; 
p-values less than 0.05 were considered significant and indicated by: 
*:p < 0.05; **:p < 0.01; ***:p < 0.001.
3. Results
3.1. Human colonic Trm are identified by CD103 and 
Runx3 and express Treg markers CD39 and CD73
To evaluate the role of Trm in IBD, we first identified Trm in 
intraepithelial lymphocytes [IEL] and lamina propria lymphocytes 
[LPL] from healthy control [HC], CD, and UC colonic biopsies 
[non-inflamed tissue; clinical and demographic patient character-
istics are shown in Tables 1–3]. In healthy IEL [Figure 1a], all T 
cells including CD8+ or γδ T cells expressed the CD69 putative Trm 
marker. However, CD103 distinguished Trm from effector memory 
T cells, which was confirmed by their intranuclear expression of the 
Runx3 transcription factor which controls the Trm transcriptional 
programme in mice.11 A  fraction of Trm expressed T-bet, which 
controls the Th1 programme of differentiation.12 In LPL [Figure 
1b], main populations were CD4+ and CD8+ T cells, and the latter 
not only contained a much larger proportion of CD103+ Trm-like 
cells but also had higher levels of Runx3 and T-bet than their CD4 
counterparts. IEL lacked CD4 cells and no γδ T cells were found in 
LPL. Trm and γδ T cells expressed high levels of the Treg markers 
CD39 and CD73, suggesting immunosuppressive function [Figure 
1c and d]. CD8 Trm were nearly all conventional T cells expressing 
CD8αβ heterodimer [Figure 1c] and no Foxp3 transcription factor 
[Figure 1d]. The vast majority of cells expressing CD39 and CD73 
were also Foxp3- [barring a small fraction of the CD4 Trm], sug-
gesting that the Trm themselves contribute to maintaining tissue 
homeostasis.
3.2. Trm are deficient in Crohn’s disease and 
ulcerative colitis
Using this analysis, we next compared numbers and phenotype of 
CD8+ and CD4+ Trm and γδ T cells obtained from right colon of 
HC, CD, and UC donors [Figure 2]. We found a dramatic decrease in 
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Figure 2. Quiescent IBD is associated with reduced numbers of Trm and γδ T cells in colonic tissue. A: Numbers and percentages of CD8+ γδ TCR- CD103+ Trm 
recovered from IEL [upper graphs] and γδ CD103+ T cells in IEL [lower graphs], alongside CD39 and CD73 expression on these populations. B: Numbers and 
percentages of CD4+ CD103+ Trm [upper graphs] and CD8+ CD103+ Trm [lower graphs] recovered from LPL, alongside CD39 and CD73 expression. Full gating 
strategies are shown in supplementary methods. C: Total live cell numbers in IEL and LPL fractions [including epithelial cells]. D: Correlation of CD8 Trm and 
γδ T cell numbers in IEL populations from right colon biopsies of all donors. HC: healthy controls, n = 25; CD: Crohn’s disease, n = 12; UC: ulcerative colitis, 
n = 20. Median values ± 95% confidence intervals are shown; statistically significant differences between groups [Kruskal–Wallis test] are indicated. Spearman 
correlation coefficient was calculated in D. IEL, intraepithelial lymphocytes; LPL, lamina propria lymphocytes; IBD, inflammatory bowel disease.
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both CD8 Trm and γδ T cells in IEL in IBD patients [Figure 2a; 84% 
and 61% for CD8 Trm; 90% and 87% for γδ T cells in CD and UC, 
respectively]. Both total numbers and percentages of Trm relative to 
total live cells were reduced in IBD donors. The phenotype of CD8 
Trm was unchanged, but significantly decreased γδ T cell expression 
of CD39 was seen in UC and CD, suggesting impaired regulatory 
function. In LPL, there were also fewer Trm, although the deficiency 
was less dramatic than in IEL [61% and 44% for CD8; 28% and 
68% for CD4 in CD and UC, respectively] and did not reach stat-
istical significance for CD4 Trm in CD or when expressed in per-
centage terms [Figure 2b]. There was no change in phenotype of LPL 
Trm in disease. Total yields of viable cells in IEL and LPL were un-
changed in IBD [Figure 2c]; thus deficiencies in Trm were selective 
and could not be explained by loss of epithelium. We also found a 
strong correlation between numbers of CD8 Trm in IEL and γδ T 
cells [Figure 2d], suggesting co-dependence of these populations. In 
left colon biopsies we found significantly fewer Trm [Supplementary 
File 2 and Figure S1, available as Supplementary data at ECCO-JCC 
online] and no significant changes in IBD. The levels of Trm and γδ 
T cell deficiency were not related to disease severity, as assessed by 
macroscopic inflammation, in either disease [Figure S2, available as 
Supplementary data at ECCO-JCC online ].
3.3. Human Trm development in vitro is controlled 
by TGF-β, IFN-β, retinoic acid, and AhR receptor 
agonists
To determine possible mechanisms contributing to the deficiency of 
Trm in IBD, we studied micro-environmental factors. We developed 
an in vitro model to induce human Trm-like cells from naïve CD8 
T cells purified from healthy donor PBMC [Figure 3]. Seven days’ 
differentiation with anti-CD3/CD28 and IL-2 yielded effector cells 
with few markers of Trm with the exception of the CD73 Treg-
associated molecule, and were designated Tc1 type. We tested add-
ition of: TGF-β, a mucosal cytokine known to promote mouse Trm 
development2; IFN-β, since type 1 interferon in the gut can control 
colitis13; all-trans retinoic acid [ATRA], known to induce CD10314; 
and FICZ [5,11-dihydroindolo[3,2-b]carbazole-6-carboxaldehyde], 
an aryl hydrocarbon receptor [AhR] agonist known to promote de-
velopment of IEL.15 Different Trm markers were induced differen-
tially by each factor or combinations thereof. CD103 expression 
was dependent on TGF-β alone; CD39 was induced by IFN-β and 
FICZ, as was the Trm transcription factor Runx3. Integrin-β7, not a 
Trm marker but indicative of gut homing potential, was induced by 
a combination of TGF-β and ATRA, as was CD69, a Trm marker ex-
pressed on all intestinal T cells. Cells expressing all Trm-associated 
markers simultaneously [Figure 3b] were maximal using a com-
bination of all four factors, which were therefore used to induce 
Trm-like cells in further functional experiments. IL-15, although 
involved in mouse Trm development, had no effect in this model.
3.4. B cells are dysregulated in quiescent IBD 
patients
To determine if reduced CD8 T cells in colonic tissue of IBD pa-
tients was indicative of imbalance in cell-mediated immunity versus 
humoral immunity towards the microbiota, we examined propor-
tions of follicular helper [Tfh-like] cells, key inducers of antibody 
production through interaction with B cells in germinal centres, 
alongside the gut-homing function of T cells in PBMC [Figure 4a 
and Supplementary Figure S3, available as Supplementary data at 
ECCO-JCC online]. Tfh-like cells expressing CD4 and CXCR5 
were unchanged in IBD, as were proportions of integrin-β7+, gut-
homing cells. CD8 T cells did not express CXCR5 but showed high 
A C
B
α-CD3/CD28/IL-2 only
TGF-β
IFN-β
TGF-β + ATRA
TGF-β + ATRA + FICZ
IFN-β + ATRA
IFN-β + ATRA + FICZ
TGF-β + IFN-β + ATRA
TGF-β + IFN-β + ATRA + FICZ
ATRA
FICZ
α-CD3/CD28/IL-2 only
TGF-β
IFN-β
TGF-β + ATRA
TGF-β + ATRA + FICZ
IFN-β + ATRA
IFN-β + ATRA + FICZ
TGF-β + IFN-β + ATRA
TGF-β + IFN-β + ATRA + FICZ
ATRA
FICZ
α-CD3/CD28/IL-2 only
TGF-β
IFN-β
TGF-β + ATRA
TGF-β + ATRA + FICZ
IFN-β + ATRA
IFN-β + ATRA + FICZ
TGF-β + IFN-β + ATRA
TGF-β + IFN-β + ATRA + FICZ
ATRA
FICZ
CD103 Runx3CD39
*
*
*
* ***
**
*
*
** *
**
** *
****
*
*
****
**
*
*
**
** *
**
20 40 60 80 100
20
2 4 6 8 10 12 14
40 60 80 20 40 60 80 1005 10 15 20 25 30
10 20 30 40 50 10 20 30 40 50
Integrin β7
% CD103+CD39+
Runx3+CD69+CD73+
CD69 CD73
C
D
69
C
D
73
6.75% 99.7%
2.1%
8.52%
89.3%
35.4%
3.32%
10.6% 49.4%
0.97%
15.1%
CD103 Runx3CD39
97.9%
Tc1
cells
Trm-like
cells
In
te
gr
in
 β
7
Figure 3. Human CD8 Trm development in vitro is regulated by cytokines, vitamins, and dietary factors. A: Effects of combinations of TGF-β, IFN-β, all-trans 
retinoic acid [ATRA], and an AhR agonist [FICZ] on Trm, Treg, and homing markers in CD8 effector cells derived from CD8 naïve T cells differentiated with 
anti-CD3/CD28+IL-2 for 7 days. Graphs show mean ± standard error of the mean [SEM] from five independent experiments; groups compared using one-way 
ANOVA with Dunn’s test for multiple comparisons applied. B: Cells expressing all Trm-associated markers simultaneously were analysed as in A. C: Staining 
profiles as in A, showing example of cells cultured in anti-CD3/28 + IL-2 only [Tc1 cells] or with addition of TGF-β, IFN-β, ATRA and FICZ [Trm-like cells].
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levels of integrin-β7 indicating that their gut-homing capacity was 
not impaired in IBD. Analysis of B cell subsets in PBMC [Figure 4b, 
Table 2] showed significantly increased proportions of plasmablasts 
[CD38hi CD27+ B cells] in both CD and UC; these are a highly ac-
tivated subset destined to become plasma cells in tissues.16 Other 
B cell subsets, including those switched to IgA or IgG production, 
were unchanged. Consistent with increased B cell activity, IEM re-
leased from colonic biopsies showed significantly higher levels of 
IgA coating in both CD and UC than in HC [Figure 4c and d], al-
though numbers of microbes obtained were unchanged.
3.5. T and B cell memory responses to commensal 
bacteria indicate skewing to humoral immunity in IBD
We then analysed whether antigen-specific T and B cell responses to 
specific commensal bacteria were imbalanced in IBD [Figure 5]. We 
selected 19 commensal strains mainly isolated from healthy human 
caecum, covering as many genera as possible. Killed bacteria were 
added to PBMC for 7 days to identify specific memory CD4/CD8 T 
cell or B cell proliferative responses. Results showed responses were 
highly specific to individual species [Figure 5a and b] and showed 
high degrees of variability both between individual donors and be-
tween HC and IBD patients [Figure 5c]. Variability within responses 
of individual donors was noted after around 1 year [Supplementary 
Figure S4, available as Supplementary data at ECCO-JCC online], 
indicating that such memory is dynamic and not long-term. As ex-
pected, CD4 T cell responses were the predominant memory re-
sponse in all groups; however, total numbers of positive responses 
for each donor were unchanged in health vs IBD [Figure 5d]. By 
contrast, numbers of the less frequent CD8 T cell responses were 
significantly reduced in CD compared with HC, with the same trend 
apparent in UC [Figure 5d]. B cell memory responses to bacteria 
were rare in health but significantly increased in both CD and UC 
[Figure 5d]. T cells proliferating in response to microbes expressed 
integrin-β7 [gut-homing marker], CLA [skin-homing], and the CD39 
Treg marker, whereas B cells only expressed CLA in response to mi-
crobes [Figure 5a; Figure S3].
To investigate a possible link between circulating CD8 memory to 
commensals and recruitment of CD8 Trm to mucosa, we correlated 
numbers of CD8 responses to the 19 bacteria with CD8 Trm [IEL] 
numbers in donors where both blood and biopsies were obtained; 
this indicated a significant positive correlation [Figure 5e]. We then 
examined the magnitude of individual responses, as reflected by the 
proportion of divided cells, which is related to antigen-specific pre-
cursor frequency. Results for the most immunogenic species from 
each phylum [Figure 5f] show the high level of variability between 
donors, with a significant difference in CD8 response in health vs IBD 
revealed for Staphylococcus epidermidis only, the most immunogenic 
species. B cell responses, however, were significantly increased for all 
species in CD and UC. We also categorised numbers of proliferative 
responses against the four phyla of bacterial species [Figure S5, avail-
able as Supplementary data at ECCO-JCC online]. The same trends 
were observed in all phyla, with the most significant differences in 
CD8 and B cell responses seen in Actinobacteria and Firmicutes. We 
also performed assays for commensal-specific antibodies in plasma, 
a more conventional readout for B cell immunity. Circulating IgG 
specific for the most immunogenic species in the 19-strain panel, as 
shown in Figure 6a, showed that antibody was increased in CD but 
not UC-indeed, levels in UC were the same as those in HC and sig-
nificantly lower than in CD. Antibodies to less immunogenic species 
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were detectable but not significantly different between health and 
IBD. The divergent findings with B cell proliferative response vs cir-
culating IgG were reflected in poor correlations between the levels 
of each in individual donors; the only statistically significant cor-
relation was found with E. coli [Figure 6b]. Circulating IgA levels 
were much lower than IgG [Supplementary Figure S6, ]available as 
Supplementary data at ECCO-JCC online or undetectable, and did 
not show significant differences between health and disease.
We tested whether immune deviation seen in IBD was specific 
to microbiota or reflected a systemic bias affecting responses 
to other antigens. We chose to assess responses to classic CD8 
T cell-inducing viral antigens. Plasma were assayed for IgG to 
three non-enteric viruses encountered in childhood—varicella 
zoster [VZV], measles, and respiratory syncytial virus [RSV] 
[Figure 6c]. Antibody to VZV showed the same pattern as com-
mensals, with significantly increased levels in CD but not UC. 
Antibodies to measles were detectable in all patient groups but 
did not differ significantly, whereas few positive titres of RSV 
IgG were detected.
3.6. Mechanisms of immune deviation in IBD
The above data clearly indicated a pattern of immune deviation be-
tween cellular/cytotoxic and humoral immunity to members of the 
intestinal microbiota as an underlying feature of IBD. To examine 
potential pathogenic mechanisms, we first pursued the hypothesis 
that Trm express regulatory T cell function. We performed suppres-
sion assays using conventional Tc1-type CD8 effector cells and Trm-
like cells, generated using our in vitro model system [Figure 3]. The 
targets used in the assays were autologous PBMC stored in liquid 
nitrogen. Effector cells were added at a 1:4 ratio and an inhibitor of 
CD39 ectonucleotidase activity [ARL67156] was used to determine 
whether suppressive activity was CD39-dependent. Target CD8 T 
cell proliferation assayed after 4 days revealed suppressive activity 
in Trm but not in Tc1 cells, which was partially reversed in the pres-
ence of the CD39 inhibitor [Figure 7a]. The cultured Tc1 and Trm 
cells were also tested for cytokine production [Figure 7b], which re-
vealed that Trm cells had similar capacity for production of pro-
inflammatory cytokines IFN-γ, TNF-α, and IL-17 compared with 
Tc1; however IL-10, the key immunoregulatory cytokine in the GI 
tract,17 was significantly increased in Trm cells. Since dendritic cells 
[DCs] are critical for controlling immune deviation and tolerogenic 
responses and are a target of Treg, we analysed the interaction be-
tween T cells and DCs, again using a model system with healthy 
PBMC. To stimulate DC: T cell cognate interactions we used SEB 
superantigen, compared with TLR-mediated DC stimulation using 
LPS [Figure 7c]. We also added LPS + poly I:C + monensin to cul-
tures for the final 4 h, in order to assess DC cytokine production. SEB 
but not LPS strongly induced T-bet transcription factor expression 
in both myeloid [mDC] and plasmacytoid DC [pDC], and those DC 
expressing T-bet produced less TNF-α and more IFN-α, cytokines 
with opposing roles in colitis.13,18–20 In pDC, overall TNF-α produc-
tion was suppressed by SEB, whereas in mDC the reduced levels in 
T-bet+ DC were counterbalanced by increased TNF-α in T-bet– cells. 
The effect of T cell:DC interaction on T-bet was partially dependent 
on IFN-γ, as shown by a neutralising IFN-γ antibody, but effects on 
cytokine production appeared IFN-γ independent.
Table 1. Clinical characteristics of St Mark’s Hospital colonoscopy 
patients donating colonic biopsies.
Characteristic HC CD UC
n 23 11 18
Male/female 13/10 4/7 12/6
Median age [95% CI] at 
sampling
51.5 [41–57] 43 [28–57] 53.5 [47–60]
Median age [95% CI] at 
diagnosis 
 26 [18–47] 35 [29–42]
Inflammation: endoscopic 
subscores for UC:
   
 Mayo 0   8
 Mayo 1   3
 Mayo 2   6
 Mayo 3   1
IBD medications at sampling:    
 Aminosalicylates  4 15
Azathioprine/6-mercaptopurine 4 1
 Buscopan  1 0
 Adalimumab  1 0
 None  4 3
Non-IBD medications at 
sampling:
   
 Metformin/gliclazide/statin  0 2
 Ondansetron  1 0
 Certirazine  1 0
 None  9 16
Demographic and clinical data analysed in Figures 2, 4d, and Supplementary 
Figure S1, available as Supplementary data at ECCO-JCC online.
HC, healthy controls; CD, Crohn’s disease; UC, ulcerative colitis; CI, con-
fidence interval.
Table 2. Clinical features/Montreal classification of CD patients donating colonic biopsies.
Donor Age at diagnosis Disease location Disease behaviour Inflammation
1 A2 L3 B1 None
2 A3 L3 B1 Mucosal erosions, polyps
3 A2 L2 B1 Patchy area of inflammation, polyps
4 A1 L0 B1 None
5 A2 L3 B1 Small mucosal ulceration
6 A2 L3 B1 Ulceration, scarred colon
7 A3 L3 B1 Ulceration
8 A2 L0 B1 None
9 A2 L0 B1 None
10 A2 L0 B1 None
11 A2 L3 B1 Mild inflammation/ulceration
Demographic and clinical data analysed in Figures 2, 4d, and Figure S1, available as Supplementary data at ECCO-JCC online.
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4. Discussion
IBD is characterised by acute inflammatory episodes and pathology, 
and current treatments aim to suppress symptoms using a plethora 
of immunosuppressive strategies. Our studies here, focusing mainly 
on patients with no ulceration [CD] or a Mayo index of 1 or less 
[UC], reveal that underlying disease is characterised by reduced CD8 
T cell immunity to commensal microbes associated with a paucity 
of Trm, potentially explaining the loss of barrier immunity which 
characterises IBD and drives pathology. Reduced CD8 response can 
also explain the skewing of immunity towards B cell-mediated anti-
body production, and loss of immunoregulation in the local mucosa 
due to the reduced numbers of cells expressing key Treg molecules 
CD39 and CD73. The mutually antagonistic relationship between 
cell-mediated and humoral immunity was first noted in the 1970s21 
and was subsequently attributed to the Th1/Th2 axis,22,23 as was the 
hygiene hypothesis in immune-mediated disease.24 CD8 T cell re-
sponses skew immunity away from humoral and towards cellular 
immunity—our study is the first to examine such responses to the 
intestinal microbiota in humans and points towards novel strat-
egies in IBD treatment. Studies of anti-inflammatory commensal-
induced pathways in the gut have focused on CD4 Foxp3 Treg, 
which form a small fraction of the LPL and are absent from IEL 
in human colon. By contrast, our data show Trm could provide a 
gatekeeper function, controlling access of mucosal antigens to ger-
minal centres in lymphoid tissue, and thus Tfh:B cell interaction, 
while simultaneously controlling inflammation through breakdown 
of extracellular ATP.25,26 Runx3 has recently been defined as a master 
transcription factor for development of murine Trm.11 Our data 
show that human gut Trm preferentially express Runx3, and fur-
ther co-express CD39 and CD73, key functional molecules on Treg 
cells.27 CD39 is essential for in vitro suppressive activity of Foxp3+ 
Treg cells due to its ability to degrade extracellular ATP,28 which 
activates DC,29 and CD73 assists further nucleotide breakdown to 
adenosine, an immunosuppressive molecule.30 ATP is released in mu-
cosal tissue by injury but is also secreted by bacteria,31 explaining the 
necessity for high expression of these molecules by Trm, especially 
IEL, in comparison with circulating T cells. IEL and in vitro-derived 
Trm-like cells expressed lower levels of CD73, suggesting that fur-
ther breakdown of ADP towards adenosine occurs further into the 
mucosa. It should be noted that there are multiple other mechan-
isms via which Treg may express their function,32 and we have not 
been able to directly assess suppressive activity in tissue-derived Trm 
or compare such activity in health vs IBD, due to the low numbers 
available. Therefore, unchanged levels of CD39 and CD73 on Trm in 
IBD does not exclude the possibility of altered function.
Foxp3+ Treg are critical in systemic tolerance and in establishing 
tolerance to self-antigens in early life.33 Foxp3 was not expressed in 
CD8 T cells in the colon, which outnumber CD4 T cells. Foxp3+ Treg 
were present at a modest percentage in the CD4 LPL population 
[around 5%] and were vastly outnumbered by Foxp3-negative CD4 
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Figure 6. Circulating specific IgG antibodies to immunogenic commensal species are raised in CD but not UC donors. A: Plasma was assayed for IgG antibodies 
using a coating assay. Ratios of median fluorescence intensity of anti-IgG-stained vs isotype control for each sample are shown [median and 95% CIs]. Kruskal–
Wallis tests were used to compare groups; n = 30 HC, n = 18 CD and UC. B: Correlation of B cell proliferative responses to E. coli against circulating IgG in 40 
matched donors, including Pearson correlation coefficient. Correlations with other species were not significant. C: Antibodies against non-enteric viruses in 
health vs IBD. Plasma were assayed by ELISA for IgG to viral antigens and results expressed in arbitrary units. Grey lines represent cut-off points below which 
titres are considered negative. One-way ANOVA was used to compare groups. IBD,inflammatory bowel disease; HC, healthy controls; CD, Crohn’s disease; UC, 
ulcerative colitis; CI, confidence interval.
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and CD8 T cells, mostly Trm, expressing high levels of CD39 and 
CD73. Arguably the low number of Foxp3+ Treg in human colon is 
insufficient to maintain tolerance in the presence of such large anti-
genic loads from the microbiota, necessitating accumulation of Trm 
populations with regulatory capacity. Since Trm do not differentiate 
until they reach the tissue,34 this would explain why we found tol-
erance to commensal bacteria was not systemic, but localised to the 
gut. Circulating T cells reactive to commensals would not express 
regulatory function until resident in the tissue, and would require 
local tissue factors such as type I IFN and AhR agonists to maintain 
their function. This picture contrasts with that emerging from mouse 
models, most likely due to far greater antigenic experience and ma-
turity of the adult human immune system compared with laboratory 
mice. We found higher proportions of conventional CD8αβ T cells in 
tissue than reported in mice, which may rely more on innate mech-
anisms and thymus-derived Foxp3+ Treg, due to their short lifespan. 
We also found strong correlation between αβ + and γδ + T cells in 
IEL, implying that αβ + may support γδ + cell populations in a fashion 
analogous to that demonstrated in the thymus,35 or co-dependence 
on tissue-specific environmental factors. A  further correlation was 
shown between numbers of memory CD8 responses to commensal 
bacteria and colonic CD8 Trm, suggesting that such responses are 
required to recruit and maintain healthy Trm populations. CD8 
Trm have recently been shown to be recruited to skin in response 
to skin resident microbes in a non-classical major histocompatibility 
complex [MHC]-restricted fashion.36 This mouse study demon-
strated that such Trm exhibited an unusual phenotype with expres-
sion of immunoregulatory genes and wound-healing activity, thus 
improving barrier function without inflammation. Our data suggest 
that a similar phenomenon occurs in the colon but is dependent on 
classical responses to a wide range of bacterial antigens.
One recent study demonstrated a pro-inflammatory role for Trm 
cells in active IBD,37 thus suggesting that Trm can exhibit both pro- 
and anti-inflammatory activities dependent on the context. CD4 
and CD8 Trm were increased in the lamina propria of inflamed IBD 
tissue in this study, and T cell transfer colitis experiments in mice 
confirmed that T cells adopt a Trm phenotype soon after recruit-
ment to lamina propria in active disease.37 The pathological role of 
Trm was dependent on their pro-inflammatory cytokine production 
regulated by Hobit/Blimp-1 transcription factors expressed in Trm. 
However, deletion of Hobit/Blimp-1 in mouse CD4 T cells had no 
effect on their regulatory function or development into Trm.37 A fur-
ther study compared proportions of CD103+ cells within total T cell 
populations in inflamed vs uninflamed biopsies from CD and UC 
patients.38 This study showed decreased proportions of CD103+ cells 
in inflamed tissue; however, this could have been due to influx of ef-
fector memory-type cells. Further work in murine systems targeting 
regulatory function in Trm and effects on disease susceptibility are 
therefore warranted. We propose that dual functionality of Trm 
cells in homeostatic versus inflammatory conditions would allow 
balanced immunity to occur across large areas of tissue exposed to 
high antigenic loads.
Murine studies have not clearly described the biology of CD4+ 
Trm and, unlike CD8 cells, Runx3 expression in human CD103+ 
CD4 cells in LPL was low, so we focused on CD8+ Trm activities. 
Dietary factors retinoic acid and AhR agonists could play a role in 
expression of the Trm phenotype within tissue or in Trm survival, 
in addition to the mucosal cytokine TGF-β and type 1 interferon, 
both cytokines associated with suppression of colitis.13,39–41 Gut type 
1 interferon production could be influenced by the enteric virome, 
which is also altered in IBD.42 ATRA is derived from vitamin A by 
antigen-presenting cells,39 whereas AhR agonists are dietary fac-
tors contained in cruciferous vegetables and key to gut health.15 
Combining these factors in vitro allowed us to develop the first in 
vitro differentiation model for human Trm, but also revealed dis-
tinct regulation of individual Trm-associated markers. Interestingly, 
although CD103 expression was entirely dependent on TGF-β, the 
key Trm transcription factor Runx3, and CD39 were unaffected by 
TGF-β and co-regulated by type 1 interferon and the AhR agonist. 
Thus CD103, as a migration marker, may not necessarily reflect Trm 
function in clinical studies.
Circulating IgG antibody to certain commensals was increased 
in CD but not UC, despite B cell dysfunction in UC with increased 
circulating plasmablasts and IgA secretion. Since inflammatory le-
sions penetrate deeper into intestinal tissue in CD than in UC,43 and 
there is more involvement of mesenteric lymph nodes in CD than 
in UC,44,45 it is possible that longer-lived, higher-affinity antibody 
responses are generated in CD, as antigens could access germinal 
centres in lymph nodes driving affinity maturation. Circulating B cell 
Table 3. Clinical characteristics of St Mark’s Hospital blood donors 
and healthy volunteers.
Characteristic HC CD UC
n 18 17 14
Male/female 13/5 8/9 7/7
Median age [95% CI] at 
sampling
41.5 [30–54] 43.5 [33–61] 54.5 [35–63]
Median age [95% CI] at 
diagnosis 
 25 [20–44] 38.5 [25–47]
Symptoms at sampling:    
 Diarrhoea/loose stools  1 2
 Occasional loose motion/
watery stool
 2 1
A bdominal pain  2 1
 Perianal pain/itch/disease  2 1
 Lethargy  2 0
 Proctitis  0 1
 None  9 8
IBD medications at 
sampling:
   
 Aminosalicylates  8 8
 Azathioprine/6-
mercaptopurine
 8 2
 Corticosteroids  1 0
 Vedolizumab  1 0
 Antibiotics  1 0
 Methotrexate  1 0
 None  1 6
Non-IBD medications at 
sampling:
   
 Vitamins D/D3/B12/multi  4 3
 Metformin/gliclazide  0 2
 Statins  1 2
 Hydroxychloroquine  0 1
 Proton pump inhibitor  0 1
 Alendronate  1 0
 Finasteride  1 0
 Loperamide  1 1
 None  12 9
Demographic and clinical data analysed in Figures 4, 5, amd Figs S2, S3, S4, 
available as Supplementary data at ECCO-JCC online.
HC, healthy controls; CD, Crohn’s disease; UC, ulcerative colitis; IBD, 
inflammatory bowel disease; CI, confidence interval.
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proliferative responses may reflect shorter-term responses with more 
broadly reactive antibody synthesis focused on mucosa. Indeed, re-
peat assays on individual healthy donors showed memory responses 
to commensal bacteria could change within a year, and long-term 
memory is not required for non-pathogenic organisms. The excessive 
IgA response to mucosa-associated microbes was apparent in both 
CD and UC but was not accompanied by increased circulating Tfh-
like cells. Future work could examine microbe-specific Tfh cells, but 
these might be sequestered in lymphoid tissue.
Mechanisms through which CD8 T cells might control immune de-
viation are not entirely clear, but they are known to regulate CD4 T cell 
development. Here CD4 responses were not altered in IBD, but we did 
not examine their cytokine profiles, which are skewed towards a Th17 
profile in IBD.4 Th17 development is strongly inhibited by IFN-γ,46 the 
major product of CD8 T cells. Our data show that an additional mech-
anism could be via induction of T-bet in DCs, either via interaction 
with tissue-resident T cells reactive to microbial antigens, or in draining 
lymphoid tissues. T-bet expression in DC is critical in preventing colitis 
in mice, since it represses production of TNF-α.18,47 Consistent with 
this concept, we found interaction with T cells suppressed TNF-α in 
pDC while enhancing IFN-α production in DC, although these effects 
were less specific to T cells and IFN-γ. This novel pathway may con-
tribute to immune deviation and allow acquired immune memory to 
reinforce DC activity in tissues. Dialogue between Trm and DC in tissue 
may inform appropriate type of memory response as well as directing 
tissue migration of effector cells. Current dogma states that DC direct 
T cell responses after integrating signals from innate immunity and 
tissue damage. However, additional dialogue between tissue DC and 
Trm would allow for more intelligent decision making based on host 
immunological experiences, thus allowing the gut immune system to 
learn which bacteria are pathogenic over time.
IBD is a clear example of a ‘Western’ disease associated with 
dysbiosis and disrupted immunoregulation.48 Our data establish IBD 
as a disease of B cell dysfunction and point towards deficient CD8 
T cell priming to the microbiota as key to its aetiology. IBD often 
exhibits extra-intestinal manifestations,49 and several other diseases 
are associated with intestinal dysbiosis. It is therefore possible that re-
duced Trm priming is a general mechanism underlying the hygiene hy-
pothesis in immune-mediated disease, and associations of microbiota 
with tumour development and cancer therapy.50,51 Memory CD8 T 
cells migrate to multiple tissues and escape homeostatic control mech-
anisms that limit their numbers in the circulation,52 so numbers of 
Trm can accumulate throughout life in response to immunological 
experiences. Notably, CD8 Trm accumulate throughout childhood in 
humans,53 when IBD is often first diagnosed. Since CD8 responses are 
typically used for dealing with highly pathogenic organisms, a lack of 
exposure to enteric pathogens in early life could result in weakened 
tissue immunity and thus an altered microbiota. Evidence for this in 
IBD was provided by the increased antibody response to VZV seen in 
CD. VZV is latent and requires constant immune surveillance by cyto-
toxic T cells; thus increased antibody may reflect weaker cytotoxic 
control of virus, although this was not the case for measles and RSV.
Manipulating immunity to intestinal microbiota through vac-
cination may address the underlying disease process, unlike current 
immunosuppressive strategies. It may prove of greater therapeutic 
benefit than changing the microbiota itself in a range of diseases as-
sociated with dysbiosis, since every patient will respond differently 
to any particular microbe/cohort, due to MHC differences. Mice 
that lack T-bet expression in their innate immune system develop 
altered microbiota which is colitogenic,18 indicating that dysbiosis is 
secondary to immune changes. Vaccination would need specifically 
to target CD8 T cell responses; inducing cytotoxic activity against 
target microbes may eliminate them from the microbiota, thus 
preventing pathology. The concept that immunisation to induce 
CD8 T cell responses can suppress inflammatory pathology may be 
counter-intuitive, but proof of principle for this was demonstrated in 
mouse models of airway disease.54,55 Such vaccination could provide 
long-lasting effects on the highly plastic DCs that direct immune re-
sponses into pathways associated with health or disease.
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